Connor, Clark & Lunn Investment Management (CC&L)’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-61,589
| Closed | -$1.97M | – | 1288 |
|
|
2022
Q2 | $1.97M | Buy |
61,589
+54,486
| +767% | +$1.74M | 0.01% | 474 |
|
|
2022
Q1 | $246K | Sell |
7,103
-12,796
| -64% | -$443K | ﹤0.01% | 913 |
|
|
2021
Q4 | $582K | Sell |
19,899
-108,780
| -85% | -$3.18M | ﹤0.01% | 773 |
|
|
2021
Q3 | $3.28M | Buy |
+128,679
| New | +$3.28M | 0.02% | 424 |
|